Cargando…
Clinical perspectives in congenital adrenal hyperplasia due to 3β-hydroxysteroid dehydrogenase type 2 deficiency
PURPOSE: 3β-hydroxysteroid dehydrogenase type 2 deficiency (3βHSD2D) is a very rare variant of congenital adrenal hyperplasia (CAH) causing less than 0.5% of all CAH. The aim was to review the literature. METHODS: PubMed was searched for relevant articles. RESULTS: 3βHSD2D is caused by HSD3B2 gene m...
Autores principales: | Al Alawi, Abdullah M., Nordenström, Anna, Falhammar, Henrik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6420607/ https://www.ncbi.nlm.nih.gov/pubmed/30719691 http://dx.doi.org/10.1007/s12020-018-01835-3 |
Ejemplares similares
-
Extensive Bilateral Adrenal Rest Testicular Tumors in a Patient With 3β-Hydroxysteroid Dehydrogenase Type 2 Deficiency
por: Lolis, Evangelos, et al.
Publicado: (2018) -
Update on the Swedish Newborn Screening for Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency
por: Zetterström, Rolf H., et al.
Publicado: (2020) -
Long-Term Outcomes of Congenital Adrenal Hyperplasia
por: Nordenström, Anna, et al.
Publicado: (2022) -
Congenital adrenal hyperplasia in the Nordic countries – a potential base for long-term outcome studies
por: Nordenström, Anna, et al.
Publicado: (2023) -
Characteristics of In2G Variant in Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency
por: Kocova, Mirjana, et al.
Publicado: (2022)